Another point that came out at the meeting , they already have their endpoints for the phase1 trial but will be continuing to further evaluate the immune response , palliative effects and further establish the best dosage for phase 2 .
SBP
solbec pharmaceuticals limited
meeting, page-2
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)